Enzo Biochem (ENZ) reported Q4 EPS of $, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $32.6 million, versus $0 reported last year.
Enzo Biochem (ENZ) reported Q4 EPS of $, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $32.6 million, versus $0 reported last year.